Why the study?
How does prasugrel compare to clopidogrel as antiplatelet therapy in patients with acute coronary syndromes or undergoing percutaneous coronary intervention?
How does prasugrel compare to clopidogrel as antiplatelet therapy in patients with acute coronary syndromes or undergoing percutaneous coronary intervention?
Answers are grounded in this paper and cite their sources.
This review provides an overview of prasugrel and compares it with clopidogrel for patients requiring antiplatelet therapy after ACS or PCI.
The authors provide information on prasugrel, compare and contrast it with clopidogrel, and review the use of prasugrel in patients who require an antiplatelet agent.
No takes yet. Share an insight, caveat, or question.
Fletcher et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: